Northern Trust Corp Oyster Point Pharma, Inc. Transaction History

Northern Trust Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$7.95 - $11.68 $35,329 - $51,905	4,444 Added 12.68%	39,501 $441,000
Q3 2022 Nov 14, 2022	BUY	$4.41 - $8.38 $16,158 - $30,704	3,664 Added 11.67%	35,057 $197,000
Q2 2022 Aug 12, 2022	SELL	$3.6 - $11.2 $263,808 - $820,736	-73,280 Reduced 70.01%	31,393 $136,000
Q1 2022 May 13, 2022	SELL	$8.58 - $17.65 $43,303 - $89,079	-5,047 Reduced 4.6%	104,673 $1.22 Million
Q4 2021 Feb 08, 2022	SELL	$10.17 - $18.96 $14,431 - $26,904	-1,419 Reduced 1.28%	109,720 $2 Million
Q3 2021 Nov 15, 2021	SELL	$11.67 - $18.07 $85,961 - $133,103	-7,366 Reduced 6.22%	111,139 $1.32 Million
Q2 2021 Aug 13, 2021	BUY	$16.25 - $21.51 $440,586 - $583,200	27,113 Added 29.67%	118,505 $2.04 Million
Q1 2021 May 12, 2021	SELL	$17.92 - $25.86 $191,439 - $276,262	-10,683 Reduced 10.47%	91,392 $1.67 Million
Q4 2020 Feb 11, 2021	BUY	$18.13 - $25.18 $46,829 - $65,039	2,583 Added 2.6%	102,075 $1.92 Million
Q3 2020 Nov 16, 2020	BUY	$17.83 - $29.12 $116,447 - $190,182	6,531 Added 7.03%	99,492 $2.1 Million
Q2 2020 Aug 14, 2020	BUY	$27.86 - $35.93 $665,073 - $857,720	23,872 Added 34.55%	92,961 $2.68 Million
Q1 2020 May 14, 2020	BUY	$23.65 - $40.96 $83,602 - $144,793	3,535 Added 5.39%	69,089 $2.42 Million
Q4 2019 Feb 14, 2020	BUY	$13.55 - $26.15 $888,256 - $1.71 Million	65,554 New	65,554 $1.6 Million

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.